Strengthening research and science leadership capacity of early- and mid-career research scientists in Africa and India.
IAVI and WomenLift Health explore why investing in women’s leadership development in science is beneficial to global health research.
A new brief calls on decision-makers to prioritize tuberculosis vaccine R&D in all global health and antimicrobial resistance agendas.
The Ministry will award IAVI €21 million over the next five years as part of the Product Development Partnership IV Fund.
Three regulatory experts discuss alternative approaches for demonstrating the effectiveness of vaccines against deadly filoviruses.
New IAVI white paper identifies critical gaps across R&D, equitable access, and financing.
This EGM characterizes the evidence base of SBCC interventions for strengthening HIV prevention and research among AGYW in LMICs.
Janssen-sponsored trial discontinued due to lack of efficacy.
Reflecting on the Ebola Sudan outbreak in Uganda, Swati Gupta suggests a global solution to prepare for emerging infectious disease outbreaks.
Blog perspective from a graduate of the first cohort of the IAVI ADVANCE Leadership Development Program.
First shipment of IAVI’s Sudan virus (SUDV) vaccine candidate has arrived in Entebbe, Uganda.
+254 71 904 3142
+31 20 521 0343
+91 11 4737 6025
+1 212 847 1049